CyBio, Promega to Co-Develop High-Throughput Liquid-Handling Apps | GenomeWeb
NEW YORK (GenomeWeb News) — CyBio and Promega plan to co-develop and co-market new high-throughput liquid-handling applications based on CyBio’s liquid-handling instruments, the company said today.
 
Under the agreement, CyBio and Promega will jointly develop and market validated application protocols for high-throughput screening processes in drug development and life science research.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.